Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Completed 2 Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 50 Carcinoma, Non-Small-Cell Lung 36 Ovarian Neoplasms 35 Stomach Neoplasms 31 Esophageal Neoplasms 26 Uterine Cervical Neoplasms 20 Esophageal Squamous Cell Carcinoma 18 Fallopian Tube Neoplasms 16 Lung Neoplasms 13 Carcinoma, Ovarian Epithelial 13 Head and Neck Neoplasms 9 Triple Negative Breast Neoplasms 8 Neoplasms 8 Carcinoma, Squamous Cell 8 Recurrence 7 Neoplasm Metastasis 6 Endometrial Neoplasms 6 Advanced Gastric Cancer 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Nasopharyngeal Neoplasms 5 Hypopharyngeal Neoplasms 4 Oropharyngeal Neoplasms 3 Nasopharyngeal Carcinoma 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Carcinoma 3 Anus Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Testicular Neoplasms 2

Interventions

Doxorubicin 2 genexol-PM 1 brostallicin 1 avelumab 1 Urination 1 Temozolomide 1 Surveys and Questionnaires 1 Sorafenib 1 Radiotherapy 1 Propranolol 1 Paclitaxel 1 Neoadjuvant Therapy 1 Molecular Diagnostic Techniques 1 Microarray Analysis 1 Interviews as Topic 1 Ifosfamide 1 Chemotherapy, Adjuvant 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hemangiosarcoma × Paclitaxel × Clear all

NCT03512834 2018-07-11

ASAP

Dong-A University Hospital

Phase 2 Unknown

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡